Treatment device based on multifunctional myoelectricity biofeedback

By combining electromyography feedback, ultrasonic acupoint stimulation, red/near-infrared phototherapy, vertical local vibration and negative pressure mechanical stimulation, the problems of large equipment and long treatment time in the existing technology are solved, and efficient post-stroke The treatment of motor dysfunction improves patient compliance and rehabilitation effects.

CN222033419UActive Publication Date: 2024-11-22SHENZHEN ANTEBELL TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202322587004.1
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2023-09-22
Publication Date
2024-11-22
Estimated Expiration
2033-09-22

AI Technical Summary

Technical Problem

In the treatment of post-stroke motor dysfunction, the equipment is large in size and long in treatment, making it difficult to meet the patient's compliance and is difficult to use in family and community rehabilitation centers.

Method used

Design a therapeutic device based on multifunctional electromyography biofeedback, combining five physical factors such as electromyography feedback, ultrasonic acupoint stimulation, red/near-infrared phototherapy, vertical local vibration and negative pressure mechanical stimulation, and coordinated treatment through multiple factors. , improve the healing effect.

Benefits of technology

Through collaborative treatment, the muscle contraction function of stroke patients is improved, the spasm is suppressed, the motor function is improved, the pain and swelling is reduced, the tissue metabolism and blood circulation is enhanced, the brain function reconstruction is promoted, and the patient's compliance and rehabilitation effect is improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN222033419U_ABST
    Figure CN222033419U_ABST
Patent Text Reader

Abstract

The utility model discloses a treatment device based on multifunctional myoelectricity biofeedback. The treatment device comprises a myoelectricity biofeedback treatment work station. The myoelectricity biofeedback treatment workstation comprises a myoelectricity biofeedback treatment instrument, a myoelectricity biofeedback treatment three-electrode, a gait motion sensing terminal, a myoelectricity signal acquisition electrode, an electrical stimulation electrode, a two-in-one ultrasonic acupoint stimulation electrode and a double-sided composite physical factor treatment terminal; the myoelectricity biofeedback therapeutic apparatus comprises a two-channel myoelectricity feedback therapeutic device, a two-channel myoelectricity gait electrical stimulation therapeutic device, a two-channel ultrasonic therapeutic device, a planning therapy execution driving unit and an upper computer. Therefore, by combining five physical factor therapy for rehabilitation treatment of post-stroke limb movement dysfunction, multiple physical factors are adopted for independent or collaborative treatment, and the purpose of improving the curing effect is achieved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model relates to the field of medical rehabilitation equipment, in particular to a therapeutic device based on multifunctional electromyographic biofeedback. Background Art

[0002] Stroke is one of the most important diseases that currently affect human life and health. Post-stroke hemiplegia mainly refers to damage to the higher centers of the brain, inability to control limb movements normally, and disruption of original reflex activities. The main symptoms are uncoordinated movements between muscle groups, abnormal muscle tension, and chronic diseases characterized by shoulder-hand syndrome. There are limb autonomic dysfunction and inflammation, which affect normal balance and walking function.

[0003] The recovery of motor dysfunction after stroke is a complex process, in which repeated sensory input stimulation is considered to be one of the most effective mechanisms to promote the reorganization of cortical structure and function. At present, in the application of physical factor therapy, one is to use electromyographic biofeedback (EMG-BFB) technology to provide feedback stimulation based on the patient's remaining muscle active contraction participation components, and to give muscle electrical stimulation of corresponding intensity while performing active contraction to increase central input and reshape limb function. The second is to use focal muscle vibration therapy (FMV), which has a certain effect on the treatment of stroke sequelae such as limb movement disorders, proprioception, spasticity, contracture, shoulder-hand syndrome, and lateral neglect, especially stimulating the neuromuscular stretch reflex with a smaller exercise load to achieve effective exercise rehabilitation effects, greatly improving patient compliance. It is especially suitable for chronic patients with impaired motor function, weakness or disability.

[0004] At present, in the treatment of movement disorders after stroke, basically these two double-sided composite physical factor treatment terminals are used separately for rehabilitation treatment of patients. The equipment is large in size, and rehabilitation therapists need to replace different double-sided composite physical factor treatment terminals according to the patient's condition. Especially when performing local vibration therapy, rehabilitation therapists need to treat the patient's muscle groups one-on-one. The treatment time is long, and it is difficult to meet the patient's compliance. In addition, the equipment is large in size and difficult to sink to home patient rehabilitation and community rehabilitation centers. Therefore, a treatment device that can combine multiple physical factors for rehabilitation treatment should be designed for the recovery process of movement dysfunction after stroke to solve the above problems. Utility Model Content

[0005] In view of this, the utility model aims to address the deficiencies in the prior art, and its main purpose is to provide a therapeutic device based on multifunctional electromyographic biofeedback, which is aimed at the rehabilitation treatment of limb motor dysfunction after stroke, and adopts multiple physical factors for individual or coordinated treatment to improve the healing effect.

[0006] In order to achieve the above purpose, the utility model adopts the following technical solutions:

[0007] A multifunctional electromyographic biofeedback-based therapeutic device, comprising an electromyographic biofeedback therapeutic workstation;

[0008] The electromyographic biofeedback treatment workstation includes an electromyographic biofeedback treatment instrument, three electromyographic biofeedback treatment electrodes, a gait motion sensing terminal, an electromyographic signal acquisition electrode, an electrical stimulation electrode, a two-in-one ultrasonic acupoint stimulation electrode, and a double-sided composite physical factor treatment terminal;

[0009] The electromyographic biofeedback therapeutic apparatus comprises a two-channel electromyographic feedback therapeutic device, a two-channel electromyographic gait electrical stimulation therapeutic device, a two-channel ultrasonic therapeutic device, a planning treatment execution drive unit and a host computer;

[0010] The two-channel electromyographic feedback treatment device has a main control chip A, which is respectively connected to the host computer and the three electrodes for electromyographic biofeedback treatment; the two-channel electromyographic gait electrical stimulation treatment device has a main control chip B, a two-channel electromyographic signal acquisition device and a two-channel electrical stimulation treatment device, and the main control chip B is connected to the host computer; one end of the two-channel electromyographic signal acquisition device is connected to the main control chip B, and the other end is connected to the electromyographic signal acquisition electrode; one end of the two-channel electrical stimulation treatment device is connected to the main control chip B, and the other end is connected to the electrical stimulation electrode; the gait motion sensor terminal is connected to the main control chip B; the two-channel ultrasonic treatment device has a main control chip C, which is connected to the host computer, and the two-in-one ultrasonic acupoint stimulation electrode is connected to the main control chip C; the planned treatment execution drive unit has a controller, the controller is connected to the host computer, and the double-sided composite physical factor treatment terminal is connected to the controller.

[0011] As a preferred solution: the two-channel electromyographic feedback treatment device includes two electromyographic biofeedback drive units, and the electromyographic biofeedback drive unit includes an electromyographic signal acquisition unit, a functional electrical stimulation drive unit, a functional electrical stimulation high-voltage power supply, an RS485 interface A and the main control chip A; the main control chip A is respectively connected to the electromyographic signal acquisition unit, the functional electrical stimulation drive unit, the functional electrical stimulation high-voltage power supply and the RS485 interface A, and the RS485 interface A is connected to the host computer;

[0012] One of the electromyographic biofeedback drive units is connected to one end of connector A, and the other end of connector A is connected to the three electrodes for electromyographic biofeedback treatment; another electromyographic biofeedback drive unit is connected to one end of connector B, and the other end of connector B is connected to another three electrodes for electromyographic biofeedback treatment.

[0013] As a preferred solution: the two-channel electromyography gait electrical stimulation treatment device also includes a TMUX8211 high-voltage analog switch, an RS485 interface B and a power supply management module; the TMUX8211 high-voltage analog switch is connected to the main control chip B; the RS485 interface B is connected between the main control chip B and the host computer; there are two gait motion sensor terminals and two power supply management modules, and the two gait motion sensor terminals are respectively connected to one end of connectors C and D, and the other ends C3, C4, D3, and D4 of connectors C and D are connected to the signal end of the main control chip B, and the power supply ends C1, C2, D1, and D2 of the other ends of connectors C and D are correspondingly connected to two power supply management modules.

[0014] As a preferred solution: the two-channel electromyographic signal acquisition device includes two electromyographic signal acquisition units and two electromyographic signal acquisition electrodes, one electromyographic signal acquisition unit is connected to the main control chip B and to one end of the connector E, and the other end of the connector E is connected to one of the electromyographic signal acquisition electrodes; the other electromyographic signal acquisition unit is connected to the main control chip B and to one end of the connector F, and the other end of the connector F is connected to another electromyographic signal acquisition electrode.

[0015] As a preferred solution: the two-channel electrical stimulation therapy device includes two electrical stimulation driving units and two electrical stimulation high-voltage power supplies; the electrical stimulation high-voltage power supplies are correspondingly connected to the electrical stimulation driving units, and the two electrical stimulation driving units and the two electrical stimulation high-voltage power supplies are respectively connected to the main control chip B.

[0016] As a preferred solution: the output signal of one electrical stimulation driving unit is respectively connected to D1, D2, D3, and D4 at one end of the TMUX8211 high-voltage analog switch; the output signal of another electrical stimulation driving unit is connected to one end of connector H, the other end of connector H is connected to the electrical stimulation electrode, the other end S1 and S3 of the TMUX8211 high-voltage analog switch are respectively connected to connector G, and the other end of connector G is connected to another electrical stimulation electrode.

[0017] As a preferred solution: the two-channel ultrasonic treatment device also includes two ultrasonic drive units and an RS485 interface C, one ultrasonic drive unit is connected to I2 and I3 at one end of connector I, and the other ultrasonic drive unit is connected to J2 and J3 at one end of connector J; one end I1 of connector I is connected to the other end S2 of the TMUX8211 high-voltage analog switch; one end J1 of connector J is connected to the other end S4 of the TMUX8211 high-voltage analog switch; the main control chip C is respectively connected to the two ultrasonic drive units and the RS485 interface C, and the RS485 interface C is connected to the host computer; there are two two-in-one ultrasonic acupoint stimulation electrodes, one of which is connected to connector I, and the other is connected to connector J.

[0018] As a preferred solution: the double-sided composite physical factor treatment terminal includes a shell, a vertical local magnetic vibration composite factor treatment device and an electromyographic biofeedback composite factor treatment device, the shell includes a middle shell and a silicone pad, the middle shell is hollow inside, and is connected to each other from top to bottom to form upper and lower openings, and the silicone pad is sleeved on the upper opening of the middle shell; the vertical local magnetic vibration composite factor treatment device and the electromyographic biofeedback composite factor treatment device are respectively installed inside the middle shell, and the output end of the vertical local magnetic vibration composite factor treatment device is exposed at the upper opening of the middle shell, and the output end of the electromyographic biofeedback composite factor treatment device is exposed at the lower opening of the middle shell; the planned treatment execution drive unit is respectively connected to the vertical local magnetic vibration composite factor treatment device and the electromyographic biofeedback composite factor treatment device.

[0019] As a preferred embodiment: the vertical local magnetic vibration composite factor therapeutic device includes a vertical local magnetic vibration device, a red light / near infrared unit, a negative pressure air circuit unit and at least one ultrasonic transducer unit, the vertical local magnetic vibration device has a massage head, the red light / near infrared unit has a red light / near infrared light source, the negative pressure air circuit unit has a negative pressure suction port, the ultrasonic transducer unit has an ultrasonic metal head, and the massage head, red light / near infrared light source, negative pressure suction port and ultrasonic metal head are all located at the upper end opening of the middle shell.

[0020] As a preferred embodiment: the electromyographic biofeedback composite factor treatment device includes a red light / near infrared unit and at least one ultrasonic transducer unit, the red light / near infrared unit includes a red light / near infrared light source, a PCB board and a light-transmitting panel, a third sunken step for supporting the PCB board is arranged on the inner side of the lower end opening of the middle shell body, and the PCB board is installed on the third sunken step; the red light / near infrared light source is electrically installed on the PCB board; a fourth sunken step is arranged on the inner side of the lower end opening of the middle shell body, and the light-transmitting panel is installed on the fourth sunken step and is located above the red light / near infrared light source; the ultrasonic transducer unit includes an ultrasonic metal head and an ultrasonic ceramic sheet, the ultrasonic metal head is installed on the light-transmitting panel, and the ultrasonic ceramic sheet is located inside the ultrasonic metal head.

[0021] Compared with the prior art, the utility model has obvious advantages and beneficial effects. Specifically, it can be seen from the above technical scheme that the five physical factor therapies of combining electromyography biofeedback therapy, two-in-one ultrasonic acupoint electrical stimulation therapy, near-infrared light therapy, vertical local vibration therapy, and negative pressure mechanical stimulation provide a means for the treatment of chronic diseases such as movement disorders after stroke, swelling and pain symptoms in patients with shoulder-hand syndrome.

[0022] 1. Treat upper limb movement disorders after stroke through electromyography biofeedback, improve the muscle contraction function of the paralyzed side of stroke patients, inhibit the muscle tension of spastic muscles, and thus improve the patient's motor function.

[0023] 2. Through low-intensity pulsed ultrasound (LIPUS) combined with electrical stimulation technology, the three biophysical effects of ultrasound, namely thermal, mechanical and physical and chemical, are used to affect the material metabolism process of cells, produce a fine cell massage effect, accelerate the excretion of metabolic products, improve cell ischemia and hypoxia, improve tissue nutrition, and enhance the regeneration capacity of cell tissues. At the same time, functional electrical stimulation is combined with muscles that have lost nerve control to cause them to contract, in order to replace or correct the lost functions of organs and limbs. Electrical stimulation of the motor nerves causes muscle contraction, so as to increase the functional activity of the limbs, reduce the tension of contracted muscles after limb aging, relax muscle fibers and relieve spasms.

[0024] 3. Through red light / near-infrared light therapy, it can dilate blood vessels, increase blood flow in subcutaneous tissue, improve local blood circulation, enhance tissue metabolism and lymphatic return, promote the absorption and elimination of abnormal tumors in tissues, and have an analgesic effect.

[0025] 4. Local muscle vibration therapy uses specific mechanical oscillations to vertically stimulate specific muscle tissues. This treatment can not only effectively relieve muscle tension, poor muscle contraction timing, and uncoordinated muscle group participation, but also stimulate the recruitment of active muscle fibers, increase neuromuscular connections, enhance brain excitability, promote brain function reconstruction, and improve the recovery of motor function in stroke patients.

[0026] 5. Through negative pressure mechanical stimulation treatment of local muscle tissue, a soft and relaxing massage technique is performed on the skin surface of the affected limb from the distal end to the proximal end, which repeatedly and rhythmically promotes the flow of lymph in the lymphatic vessels, accelerates the centripetal return of lymph in the tissue fluid, reduces pain receptors, and reduces the activity of the sympathetic nervous system, which is similar to the manual lymphatic drainage technique to reduce patients' upper limb edema and pain; on the other hand, mechanical vibration stimulation can stimulate the proprioceptors of muscle spindles, change the excitability of cortical pathways, reduce spasms, and at the same time activate and motor neurons, stimulate type II fibers, recruit more motor units, improve muscle coordination and contraction efficiency, and further reduce pain and relieve swelling.

[0027] In order to more clearly illustrate the structural features and effects of the present invention, it is described in detail below in conjunction with the accompanying drawings and specific embodiments. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] Figure 1 This is a schematic diagram of the principle block diagram of the therapeutic device of the utility model;

[0029] Figure 2 This is a schematic diagram of the structure of the two-in-one ultrasonic stimulation electrode of the utility model;

[0030] Figure 3 for Figure 2 Schematic diagram of the cross-sectional structure of a two-in-one ultrasound stimulation electrode;

[0031] Figure 4 This is a schematic diagram of the three-dimensional structure of the double-sided composite physical factor treatment terminal of the utility model;

[0032] Figure 5 This is a schematic diagram of the three-dimensional structure of the double-sided composite physical factor treatment terminal of the utility model from another perspective;

[0033] Figure 6 for Figure 4 AA section diagram;

[0034] Figure 7 for Figure 4 BB section diagram;

[0035] Figure 8 This is a schematic diagram of the decomposed three-dimensional structure of the double-sided composite physical factor treatment terminal of the utility model;

[0036] Fig. 9 This is a schematic diagram of the three-dimensional structure of the double-sided composite physical factor treatment terminal of the utility model from another perspective;

[0037] Fig.10 This is a schematic diagram of a control method based on a multifunctional electromyographic biofeedback therapeutic device of the present utility model;

[0038] Fig.11 This is a schematic diagram of a control method of the electromyographic biofeedback therapeutic device of the present utility model;

[0039] Fig.12 This is a schematic diagram of the connection principle of the double-sided composite physical factor treatment terminal and the planned treatment execution drive unit of the utility model;

[0040] Fig.13 This is a schematic diagram of the control flow of the vertical local magnetic vibration compound factor treatment device of the utility model;

[0041] Fig.14 This is a schematic diagram of the control flow of the myoelectric biofeedback composite factor treatment device of the utility model;

[0042] Fig.15 This is a flow chart of the control method of the two-in-one ultrasonic acupoint stimulation therapeutic device of the present utility model.

[0043] Description of the accompanying drawings:

[0044] 10. Shell; 11. Middle shell; 111. First sinking step; 112. Support column; 113. Second sinking step; 114. Annular groove; 115. Third sinking step; 116. Fourth sinking step; 12. Silicone pad; 13. Upper opening; 14. Lower opening; 15. Negative pressure adsorption area; 16. Rubber ring; 17. Mask; 18. Handle; 20. Vertical local magnetic vibration compound factor treatment device; 21. Vertical local magnetic vibration device; 211. Massage head; 212. Fixing board; 213, vibrating magnet; 214, winding rack; 215, spring; 22, red light / near infrared unit; 221, red light / near infrared light source; 222, PCB board; 223, light-transmitting panel; 23, negative pressure air circuit unit; 231, negative pressure air inlet; 232, negative pressure air tube; 24, ultrasonic transducer unit; 241, ultrasonic metal head; 242, ultrasonic ceramic sheet; 30, electromyographic biofeedback composite factor treatment device; 31, red light / near infrared unit; 32, ultrasonic transducer unit;

[0045] 100. Electromyographic biofeedback therapy device; 200. Work trolley; 300. External display screen; 400. Three electrodes for electromyographic biofeedback therapy; 500. Gait motion sensing terminal; 600. Electromyographic signal acquisition electrode; 700. Electrical stimulation electrode; 800. Two-in-one ultrasonic stimulation electrode; 810. Flexible shell; 820. Ultrasonic transducer; 830. Conductive adhesive; 900. Double-sided composite physical factor therapy terminal. DETAILED DESCRIPTION

[0046] The utility model Figures 1 to 15 As shown, a therapeutic device based on multifunctional electromyographic biofeedback comprises an electromyographic biofeedback therapeutic workstation, wherein:

[0047] The electromyographic biofeedback treatment workstation includes an electromyographic biofeedback treatment instrument 100, a work trolley 200, an external display screen 300, three electromyographic biofeedback treatment electrodes 400, a gait motion sensing terminal 500, an electromyographic signal collection electrode 600, an electrical stimulation electrode 700, a two-in-one ultrasonic acupoint stimulation electrode, and a double-sided composite physical factor treatment terminal 900.

[0048] The electromyographic biofeedback therapeutic apparatus 100 includes a shell 910, a two-channel electromyographic feedback therapeutic device installed in the shell 910, a two-channel electromyographic gait electrical stimulation therapeutic device, a two-channel ultrasonic therapeutic device, a planned treatment execution drive unit, a host computer with Bluetooth function, a TMUX8211 high-voltage analog switch, connectors A, B, C, D, E, F, G, H, I, J, K, L, an air path connector, an air path pipeline, and an RS485 interface F.

[0049] The TMUX8211 high-voltage analog switch control signal is connected to the main control chip B, the input signal channels are respectively connected to the electrical stimulation drive unit, and the output signal channels are respectively connected to the connectors G, I, and J, so that the stimulation signal can be output to the electrical stimulation electrode 700 and the two-in-one ultrasonic acupoint stimulation electrode; the voltage output signal of the power supply management unit is connected to the two-channel electromyographic feedback treatment device, the two-channel electromyographic gait electrical stimulation treatment device, the two-channel ultrasonic treatment device, the planned treatment execution drive unit, and the TMUX8211 high-voltage analog switch; the host computer communication signal with Bluetooth function is connected to the two-channel electromyographic feedback treatment device, the two-channel electromyographic detection electrical stimulation treatment device, the two-channel ultrasonic treatment device, and the planned treatment execution drive unit through the RS485 interface F via the 485 bus.

[0050] The two-channel electromyographic feedback treatment device has a main control chip A, which is respectively connected to the host computer and the three electromyographic biofeedback treatment electrodes 400; the two-channel electromyographic gait electrical stimulation treatment device has a main control chip B, a two-channel electromyographic signal acquisition device and a two-channel electrical stimulation treatment device, and the main control chip B is connected to the host computer; one end of the two-channel electromyographic signal acquisition device is connected to the main control chip B, and the other end is connected to the electromyographic signal acquisition electrode 600; one end of the two-channel electrical stimulation treatment device is connected to the main control chip B, and the other end is connected to the electrical stimulation electrode 700; the gait motion sensor terminal 500 is connected to the main control chip B; the two-channel ultrasonic treatment device has a main control chip C, which is connected to the host computer, and the two-in-one ultrasonic acupoint stimulation electrode is connected to the main control chip C; the planned treatment execution drive unit has a controller, the controller is connected to the host computer, and the double-sided composite physical factor treatment terminal 900 is connected to the controller.

[0051] The two-channel electromyographic feedback treatment device includes two electromyographic biofeedback drive units, and the electromyographic biofeedback drive unit includes an electromyographic signal acquisition unit, a functional electrical stimulation drive unit, a functional electrical stimulation high-voltage power supply, an RS485 interface A and the main control chip A; the main control chip A is respectively connected to the electromyographic signal acquisition unit, the functional electrical stimulation drive unit, the functional electrical stimulation high-voltage power supply and the RS485 interface A, and the RS485 interface A is connected to the host computer.

[0052] One of the electromyographic biofeedback drive units is connected to one end of connector A, and the other end of connector A is connected to the electromyographic biofeedback treatment three electrodes 400; another electromyographic biofeedback drive unit is connected to one end of connector B, and the other end of connector B is connected to another electromyographic biofeedback treatment three electrodes 400.

[0053] The two-channel electromyography gait electrical stimulation treatment device also includes a TMUX8211 high-voltage analog switch, an RS485 interface B and a power supply management module; the TMUX8211 high-voltage analog switch is connected to the main control chip B; the RS485 interface B is connected between the main control chip B and the host computer; there are two gait motion sensor terminals 500 and two power supply management modules, and the two gait motion sensor terminals 500 are respectively connected to one end of connectors C and D, and the other ends C3, C4, D3, and D4 of connectors C and D are connected to the signal end of the main control chip B, and the power supply ends C1, C2, D1, and D2 of the other ends of connectors C and D are correspondingly connected to the two power supply management modules; the two gait motion sensor terminals 500 can realize the collection of lower limb movement limb postures for lower limb movement disorders, and the main control chip B performs analysis and evaluation.

[0054] The two-channel electromyographic signal acquisition device includes two electromyographic signal acquisition units and two electromyographic signal acquisition electrodes 600, one electromyographic signal acquisition unit is connected to the main control chip B and to one end of the connector E, and the other end of the connector E is connected to one of the electromyographic signal acquisition electrodes 600; the other electromyographic signal acquisition unit is connected to the main control chip B and to one end of the connector F, and the other end of the connector F is connected to another electromyographic signal acquisition electrode 600.

[0055] The two-channel electrical stimulation treatment device includes two electrical stimulation drive units and two electrical stimulation high-voltage power supplies; the electrical stimulation high-voltage power supplies are connected to the electrical stimulation drive units, and the two electrical stimulation drive units and the two electrical stimulation high-voltage power supplies are respectively connected to the main control chip B. The output signal of one electrical stimulation drive unit is respectively connected to D1, D2, D3, and D4 at one end of the TMUX8211 high-voltage analog switch; the output signal of the other electrical stimulation drive unit is connected to one end of the connector H, and the other end of the connector H is connected to the electrical stimulation electrode 700, and the other ends S1 and S3 of the TMUX8211 high-voltage analog switch are respectively connected to the connector G, and the other end of the connector G is connected to another electrical stimulation electrode 700.

[0056] The two-channel ultrasonic therapeutic device also includes two ultrasonic driving units and an RS485 interface C, one ultrasonic driving unit is connected to I2 and I3 at one end of connector I, and the other ultrasonic driving unit is connected to J2 and J3 at one end of connector J; one end I1 of connector I is connected to the other end S2 of the TMUX8211 high-voltage analog switch; one end J1 of connector J is connected to the other end S4 of the TMUX8211 high-voltage analog switch; the main control chip C is respectively connected to the two ultrasonic driving units and the RS485 interface C, and the RS485 interface C is connected to the host computer; there are two two-in-one ultrasonic acupoint stimulation electrodes, one of which is connected to connector I, and the other is connected to connector J.

[0057] The two-in-one ultrasonic stimulation electrode 800 includes: a flexible shell 810, an ultrasonic transducer 820, and a conductive glue 830; further, the ultrasonic transducer includes: a stainless steel electric pulse electrode sheet and an ultrasonic ceramic sheet, and the stainless steel electric pulse electrode sheet and the ultrasonic ceramic sheet are fixed as a whole by gluing; further, the I1 end of the connector I is the electric stimulation signal end, I2 and I3 are the signal ends of an ultrasonic ceramic sheet, the J1 end of the connector J is the electric stimulation end, and J2 and J3 are the signal ends of another ultrasonic ceramic sheet; further, the signal of the stainless steel electric pulse electrode sheet is respectively connected to the corresponding signals of connectors I and J; the two-in-one ultrasonic stimulation electrode 800 includes: a two-in-one ultrasonic acupoint stimulation electrode A and a two-in-one ultrasonic acupoint stimulation electrode B, and the two-in-one ultrasonic acupoint stimulation electrode A and the two-in-one ultrasonic acupoint stimulation electrode B are respectively connected to the other ends of connectors I and J.

[0058] The double-sided composite physical factor treatment terminal includes a housing, a vertical local magnetic vibration composite factor treatment device 20 and an electromyographic biofeedback composite factor treatment device 30, wherein:

[0059] The shell includes a middle shell 11 and a silicone pad 12. The middle shell 11 is hollow inside and connected to each other from top to bottom to form upper and lower openings. The silicone pad 12 is sleeved on the upper opening 13 of the middle shell 11 (the silicone pad 12 can also be replaced by other elastic and flexible materials); the vertical local magnetic vibration compound factor treatment device 20 and the electromyographic biofeedback compound factor treatment device 30 are respectively installed inside the middle shell 11, and the output end of the vertical local magnetic vibration compound factor treatment device 20 is exposed at the upper opening 13 of the middle shell 11, and the output end of the electromyographic biofeedback compound factor treatment device 30 is exposed at the lower opening 14 of the middle shell 11; the planned treatment execution drive unit is respectively connected to the vertical local magnetic vibration compound factor treatment device 20 and the electromyographic biofeedback compound factor treatment device 30. In addition, handles 18 for facilitating the lifting and placing of the double-sided composite physical factor treatment terminal are respectively provided on the two side walls of the middle shell 11.

[0060] The vertical local magnetic vibration composite factor treatment device 20 includes a vertical local magnetic vibration device 21, a red light / near infrared unit 22, a negative pressure air circuit unit 23 and at least one ultrasonic transducer unit 24, wherein the vertical local magnetic vibration device 21 has a massage head 211, the red light / near infrared unit 22 has a red light / near infrared light source 221, the negative pressure air circuit unit 23 has a negative pressure air suction port 231, and the ultrasonic transducer unit 24 has an ultrasonic metal head 241. The massage head 211, the red light / near infrared light source 221, the negative pressure air suction port 231 and the ultrasonic metal head 241 are all located at the upper end opening 13 of the middle shell 11.

[0061] The vertical local magnetic vibration device 21 also includes a fixed plate 212, a vibrating magnet 213, a winding frame 214 and a spring 215. A first sinking step 111 is provided at the upper end opening 13 of the middle shell 11. The fixed plate 212 is installed on the first sinking step 111. The winding frame 214 is fixedly connected to the lower surface of the fixed plate 212, and the interior of the winding frame 214 is hollow; the vibrating magnet 213 is vertically movably installed inside the winding frame 214; the spring 215 is installed inside the winding frame 214 and is located between the bottom wall of the winding frame 214 and the vibrating magnet 213; the massage head 211 is installed on the upper end of the vibrating magnet 213 and exposed outside the upper end opening 13 of the middle shell 11.

[0062] By loading a pulse excitation signal on the coil, the coil generates an alternating pulse magnetic field, and at the same time interacts with the constant magnetic field of the sliding magnet column set in the coil. As the direction of the magnetic field changes continuously, the suspended magnet column generates vertical mechanical vibrations. The vibration energy acts on the deep muscle tissue of the human body through the massage head 211, and produces a biological effect of local low-frequency vibration on the muscle group tissue, thereby increasing the proprioceptive input, improving the excitability of damaged nerves, promoting nerve regeneration and thus improving proprioception, increasing the excitability of the cerebral cortex, improving the ability of the central nervous system to control movement, and improving the quality of the stroke patient's movements. At the same time, the muscle group tissue has a certain intensity of alternating Under the action of the magnetic field, the blood flow in the blood vessels is accelerated, the blood circulation is improved, the cell metabolism is enhanced, the ischemic and hypoxic state of the tissue is corrected, and the transport of pain-causing substances is strengthened. On the other hand, the substances in the tissue cells move, the temperature on the friction tissue interface increases, the diffusion process of the biofilm is enhanced, the permeability of ions is increased, and the absorption and dissipation of the exudate are promoted, thereby playing the role of analgesia, anti-inflammatory and detumescence; on the other hand, the coil generates heat due to the eddy current, and the warm field is transferred to the muscle tissue by using the massage head 211 with a high thermal conductivity coefficient, causing the local skin temperature to rise, stimulating the thermal receptors in the skin, and through the thalamic reflex, the vascular smooth muscle is relaxed, the blood vessels are dilated, and the blood circulation is accelerated. Due to the heat effect, vasoactive substances are released, the vascular tension is reduced, the superficial arterioles, superficial capillaries and superficial veins are dilated, the blood circulation is accelerated, and the blood circulation is improved, thereby improving the cell nutrition environment, strengthening the cell metabolism, and fundamentally eliminating the pain recovery, and it has a certain effect on the treatment of limb movement disorders, proprioception, spasm, contracture, shoulder-hand syndrome, and unilateral neglect.

[0063] The red light / near infrared unit 22 further includes a PCB board 222 and a light-transmitting panel 223. Support columns 112 for supporting the PCB board 222 are respectively provided at the four corners of the inner side of the upper end opening 13 of the middle shell 11, and the PCB board 222 is mounted on the support columns 112; the red light / near infrared light source 221 is electrically mounted on the PCB board 222; a second sinking step 113 is provided inside the upper end opening 13 of the middle shell 11, and the light-transmitting panel 223 is mounted on the second sinking step 113 and is located above the red light / near infrared light source 221. The negative pressure air circuit unit 23 further includes a negative pressure air pipe 232, which is located inside the middle shell 11 and communicates with the negative pressure air intake port 231; the negative pressure air intake port 231 is located on the light-transmitting panel 223. The ultrasonic transducer unit 24 also includes an ultrasonic ceramic sheet 242. The ultrasonic metal head 241 is mounted on the light-transmitting panel 223. The ultrasonic ceramic sheet 242 is located inside the ultrasonic metal head 241. An annular groove 114 for embedding the silicone pad 12 is arranged around the upper end of the middle shell 11. The lower end of the silicone pad 12 is embedded in the annular groove 114. The upper end of the silicone pad 12 exceeds the upper end of the middle shell 11. The silicone pad 12 surrounds the opening 13 at the upper end of the middle shell 11 to form a negative pressure adsorption area 15. The negative pressure suction port 231 is located at the bottom of the negative pressure adsorption area 15.

[0064] The characteristics of the spectral wavelengths in the non-ionizing form of the light source in the visible and near-infrared spectra (including lasers, light-emitting diodes, and broadband light) are used to induce physiological changes and therapeutic effects. At the same time, the specific spectral irradiation has biological functions such as anti-inflammatory and tissue repair, which can effectively reduce the expression level of inflammatory factors and chemokines in PBMCs. It can play an analgesic function through the regulatory effect of inflammatory factors and chemokines on the sensitivity of nerve pain. Clinical applications have found that for chronic pain types, non-specific pain refers to pain that can neither find the exact tissue structure, pathological changes, nor the cause of the disease. The main causes may include muscle strain, myofasciitis and other diseases. Red light / near-infrared phototherapy can inhibit the expression of inflammatory factors and chemokines in PBMCs, thereby relieving pain. As a new auxiliary treatment for pain, it has a good effect on anti-inflammatory and analgesic effects on local tissues.

[0065] Transcutaneous electrical stimulation is a continuous electrical stimulation of the affected nerves, which can restore their sensitivity and block or weaken the conduction of pain. Ultrasonic therapy uses ultrasonic waves to interfere with the corresponding lesions, which can relieve symptoms such as lesion congestion, adhesion, edema, and microcirculation disorders, and then achieve pain relief and functional improvement. The combined action of the two methods of physical factors on the lesion site is beneficial to the relief of hemiplegic shoulder pain after stroke, and can enhance the improvement of upper limb function, joint mobility and analgesia.

[0066] The electromyographic biofeedback composite factor therapeutic device 30 includes a red light / near infrared unit 22 and at least one ultrasonic transducer unit 24, wherein the red light / near infrared unit 22 includes a red light / near infrared light source 221, a PCB board 222 and a light-transmitting panel 223, wherein a third sinking step 115 for supporting the PCB board 222 is provided inside the lower end opening 14 of the middle shell 11, and the PCB board 222 is mounted on the third sinking step 115; the red light / near infrared light source 221 is electrically mounted on the PCB board 222; a fourth sinking step 116 is provided inside the lower end opening 14 of the middle shell 11, and the light-transmitting panel 223 is mounted on the fourth sinking step 116 and is located above the red light / near infrared light source 221; the ultrasonic transducer unit 24 includes an ultrasonic metal head 241 and an ultrasonic ceramic sheet 242, wherein the ultrasonic metal head 241 is mounted on the light-transmitting panel 223, and the ultrasonic ceramic sheet 242 is located inside the ultrasonic metal head 241. The ultrasonic metal head 241 in the electromyographic biofeedback composite factor treatment device 30 can be used as an electrical stimulation electrode or an electromyographic signal collection electrode; in addition, an electrode can also be separately provided on the ultrasonic metal head 241. As an electromyographic signal collection electrode, the electromyographic signal of the human body can be collected in real time and fed back to the controller to make appropriate treatment parameter adjustments to improve the treatment effect.

[0067] Biofeedback functional electrical stimulation (FES) technology was used to provide feedback stimulation based on the patient's remaining muscle active contraction components. Active contraction was performed while giving muscle electrical stimulation of corresponding intensity to increase central input and reshape limb function.

[0068] The red light / near infrared light source 221 uses LED chips with different wavelengths, with a wavelength range of 600nm to 1000nm and an optical power between 40mW and 100mW. The LED chip and the PCB board 222 form a red light / near infrared matrix light source.

[0069] On the transparent panel, rubber rings 16 are provided corresponding to the ultrasonic metal head 241 and the massage head 211 to prevent the ultrasonic metal head 241 and the massage head 211 from being damaged by contact and friction with the transparent panel. In addition, a mask 17 is detachably installed at the lower opening 14 of the middle shell 11. When the myoelectric biofeedback composite factor treatment device 30 is not in use, the mask 17 can be put on the lower opening 14 of the middle shell 11 to play a protective role. In order to detect the working temperature of the vertical local magnetic vibration device 21 and the ultrasonic transducer unit 24 in real time, temperature sensors are provided on the coil wound by the winding frame 214 and on the ultrasonic metal head 241 to detect their temperature changes in real time. The temperature sensor provided on the ultrasonic metal head 241 can be attached to the groove at the top of the ultrasonic metal head 241 (a groove can be provided at the top of the ultrasonic metal head 241 to accommodate the temperature sensor). It should also be noted that the number of massage heads 211 and ultrasonic metal heads 241 can be multiple, and the specific number is set according to needs.

[0070] The double-sided composite physical factor treatment terminal can be used as a separate device or in combination with a planned treatment drive unit, or embedded in other double-sided composite physical factor treatment terminals.

[0071] The planned treatment execution drive unit includes a controller, a single or multi-channel vertical local magnetic vibration drive device (single or multi-channel vertical local vibration drive device), a single or multi-channel local magnetic stimulation drive device, a single or multi-channel ultrasonic drive power supply device, a functional low-frequency electrical stimulation drive device, an electromyographic biological signal acquisition device, a medium and low frequency nerve stimulation drive device, a red light / near infrared light source constant current drive device, a multi-channel temperature signal detection device, a negative pressure drive device and a multi-channel analog switch; the vertical local magnetic vibration drive device, the single or multi-channel ultrasonic drive device, the functional low-frequency electrical stimulation drive device, the electromyographic biological signal acquisition device, the medium and low frequency nerve stimulation drive device The excitation driving device, the red light / near infrared light source constant current driving device, the multi-channel temperature signal detection device and the negative pressure driving device are respectively connected between the controller and the multi-channel analog switch connector; the vertical local magnetic vibration compound factor therapeutic device has a connector B, the myoelectric biofeedback compound factor therapeutic device has a connector A, and the planned treatment execution driving unit also includes a connector B and a connector A. The connector B of the vertical local magnetic vibration compound factor therapeutic device is connected to the connector B of the planned treatment execution driving unit, and the connector A of the myoelectric biofeedback compound factor therapeutic device is connected to the connector A of the planned treatment execution driving unit.

[0072] The vertical local magnetic vibration driving device includes: a magnetic stimulation driving unit and a vertical local vibration driving unit. The signals of the magnetic stimulation driving unit and the vertical local vibration driving unit are linked to a controller. The controller receives a planned treatment execution instruction and controls the magnetic stimulation driving unit and the vertical local vibration driving unit to work in coordination or individually, so as to realize electromagnetic stimulation therapy, vertical vibration therapy, or vertical local muscle magnetic vibration therapy for muscle groups.

[0073] A control method for the treatment device based on multifunctional myoelectric biofeedback as described above comprises the following steps:

[0074] S1, displaying a human limb muscle treatment target graph on a host computer display screen, and processing the human limb muscle treatment target graph to generate a plurality of treatment sub-target graphs;

[0075] S2, the treatment sub-target graphics are graphics of different parts of the limbs, and different corresponding physical therapies are displayed according to the treatment target graphics of different limbs;

[0076] S3. Process the treatment target graphics of different limbs and display the control parameters of the corresponding treatment prescription. After the rehabilitation therapist adjusts the parameters of the treatment target symptoms, the control parameters of the treatment target prescription of the treatment terminal are generated and sent to the treatment terminal for independent treatment execution; allowing the user to accurately select operations in the control area of ​​the device operation page, thereby improving the user experience.

[0077] The utility model is based on a control method of a multifunctional electromyographic biofeedback therapeutic device, which aims to solve the problem of using different physical therapies for different symptoms after stroke during use of the multifunctional electromyographic biofeedback therapeutic device, and uses the treatment part as the target graph to generate a control method and control parameters for the treatment target. Different physical therapies are implemented for the treatment of different parts of the limbs, and different control parameters are used for effective treatment, so that the corresponding relationship between the treatment target part and different symptoms and related physical therapies is output to control parameters of different prescriptions, making the treatment process more intuitive and improving the ease of use and safety of the treatment device.

[0078] The design focus of the utility model is to provide a means for the treatment of chronic diseases such as movement disorders after stroke, swelling and pain symptoms of patients with shoulder-hand syndrome, etc. by combining five physical factor therapies, including electromyographic biofeedback therapy, two-in-one ultrasonic acupoint electrical stimulation therapy, near-infrared light therapy, vertical local vibration therapy, and negative pressure mechanical stimulation.

[0079] 1. Treat upper limb movement disorders after stroke through electromyography biofeedback, improve the muscle contraction function of the paralyzed side of stroke patients, inhibit the muscle tension of spastic muscles, and thus improve the patient's motor function.

[0080] 2. Through low-intensity pulsed ultrasound (LIPUS) combined with electrical stimulation technology, the three biophysical effects of ultrasound, namely thermal, mechanical and physical and chemical, are used to affect the material metabolism process of cells, produce a fine cell massage effect, accelerate the excretion of metabolic products, improve cell ischemia and hypoxia, improve tissue nutrition, and enhance the regeneration capacity of cell tissues. At the same time, functional electrical stimulation is combined with muscles that have lost nerve control to cause them to contract, in order to replace or correct the lost functions of organs and limbs. Electrical stimulation of the motor nerves causes muscle contraction, so as to increase the functional activity of the limbs, reduce the tension of contracted muscles after limb aging, relax muscle fibers and relieve spasms.

[0081] 3. Through red light / near-infrared light therapy, it can dilate blood vessels, increase blood flow in subcutaneous tissue, improve local blood circulation, enhance tissue metabolism and lymphatic return, promote the absorption and elimination of abnormal tumors in tissues, and have an analgesic effect.

[0082] 4. Local muscle vibration therapy uses specific mechanical oscillations to vertically stimulate specific muscle tissues. This treatment can not only effectively relieve muscle tension, poor muscle contraction timing, and uncoordinated muscle group participation, but also stimulate the recruitment of active muscle fibers, increase neuromuscular connections, enhance brain excitability, promote brain function reconstruction, and improve the recovery of motor function in stroke patients.

[0083] 5. Through negative pressure mechanical stimulation treatment of local muscle tissue, a soft and relaxing massage technique is performed on the skin surface of the affected limb from the distal end to the proximal end, which repeatedly and rhythmically promotes the flow of lymph in the lymphatic vessels, accelerates the centripetal return of lymph in the tissue fluid, reduces pain receptors, and reduces the activity of the sympathetic nervous system, which is similar to the manual lymphatic drainage technique to reduce patients' upper limb edema and pain; on the other hand, mechanical vibration stimulation can stimulate the proprioceptors of muscle spindles, change the excitability of cortical pathways, reduce spasms, and at the same time activate and motor neurons, stimulate type II fibers, recruit more motor units, improve muscle coordination and contraction efficiency, and further reduce pain and relieve swelling.

[0084] The technical solution of the utility model integrates five physical factors into one treatment workstation, which can realize different symptoms after stroke, adopt different physical therapies, and carry out individual or collaborative physical therapy through the control method based on multifunctional electromyography biofeedback therapy; through different treatment terminals and different stimulation electrodes, it can realize the treatment of diverse symptoms after stroke. In addition, each treatment device adopts an independent control method with a built-in main control chip to improve the safety of the operation of each treatment terminal. After the host computer with Bluetooth function configures the control parameters of each treatment device, it sends them to each treatment terminal through the 485 bus to realize the independent working treatment of each treatment device. At the same time, the host computer with Bluetooth function can monitor the working status of each treatment device to improve the safety of the operation of each treatment device.

[0085] The above description is only a preferred embodiment of the present invention and does not limit the technical scope of the present invention. Therefore, any slight modifications, equivalent changes and modifications made to the above embodiments based on the technical essence of the present invention are still within the scope of the technical solution of the present invention.

Claims

1. A therapeutic device based on multifunctional electromyographic biofeedback, characterized in that: Includes electromyography biofeedback therapy workstation; The electromyographic biofeedback treatment workstation includes an electromyographic biofeedback treatment instrument, three electromyographic biofeedback treatment electrodes, a gait motion sensing terminal, an electromyographic signal acquisition electrode, an electrical stimulation electrode, a two-in-one ultrasonic acupoint stimulation electrode, and a double-sided composite physical factor treatment terminal; The electromyographic biofeedback therapeutic apparatus comprises a two-channel electromyographic feedback therapeutic device, a two-channel electromyographic gait electrical stimulation therapeutic device, a two-channel ultrasonic therapeutic device, a planning treatment execution drive unit and a host computer; The two-channel electromyographic feedback treatment device has a main control chip A, which is respectively connected to the host computer and the three electrodes for electromyographic biofeedback treatment; the two-channel electromyographic gait electrical stimulation treatment device has a main control chip B, a two-channel electromyographic signal acquisition device and a two-channel electrical stimulation treatment device, and the main control chip B is connected to the host computer; one end of the two-channel electromyographic signal acquisition device is connected to the main control chip B, and the other end is connected to the electromyographic signal acquisition electrode; one end of the two-channel electrical stimulation treatment device is connected to the main control chip B, and the other end is connected to the electrical stimulation electrode; the gait motion sensor terminal is connected to the main control chip B; the two-channel ultrasonic treatment device has a main control chip C, which is connected to the host computer, and the two-in-one ultrasonic acupoint stimulation electrode is connected to the main control chip C; the planned treatment execution drive unit has a controller, the controller is connected to the host computer, and the double-sided composite physical factor treatment terminal is connected to the controller.

2. The multifunctional electromyographic biofeedback treatment device according to claim 1, characterized in that: The two-channel electromyographic feedback treatment device includes two electromyographic biofeedback drive units, and the electromyographic biofeedback drive unit includes an electromyographic signal acquisition unit, a functional electrical stimulation drive unit, a functional electrical stimulation high-voltage power supply, an RS485 interface A, and the main control chip A; the main control chip A is respectively connected to the electromyographic signal acquisition unit, the functional electrical stimulation drive unit, the functional electrical stimulation high-voltage power supply and the RS485 interface A, and the RS485 interface A is connected to the host computer; One of the electromyographic biofeedback drive units is connected to one end of connector A, and the other end of connector A is connected to the three electrodes for electromyographic biofeedback treatment; another electromyographic biofeedback drive unit is connected to one end of connector B, and the other end of connector B is connected to another three electrodes for electromyographic biofeedback treatment.

3. The multifunctional electromyographic biofeedback treatment device according to claim 1, characterized in that: The two-channel electromyography gait electrical stimulation therapeutic device also includes a TMUX8211 high-voltage analog switch, an RS485 interface B and a power supply management module; the TMUX8211 high-voltage analog switch is connected to the main control chip B; the RS485 interface B is connected between the main control chip B and the host computer; there are two gait motion sensor terminals and two power supply management modules, and the two gait motion sensor terminals are respectively connected to one end of connectors C and D, and the other ends C3, C4, D3, and D4 of connectors C and D are connected to the signal end of the main control chip B, and the power supply ends C1, C2, D1, and D2 of the other ends of connectors C and D are correspondingly connected to two power supply management modules.

4. The multifunctional electromyographic biofeedback treatment device according to claim 3, characterized in that: The two-channel electromyographic signal acquisition device includes two electromyographic signal acquisition units and two electromyographic signal acquisition electrodes, one electromyographic signal acquisition unit is connected to the main control chip B and to one end of the connector E, and the other end of the connector E is connected to one of the electromyographic signal acquisition electrodes; the other electromyographic signal acquisition unit is connected to the main control chip B and to one end of the connector F, and the other end of the connector F is connected to another electromyographic signal acquisition electrode.

5. The multifunctional electromyographic biofeedback treatment device according to claim 3, characterized in that: The two-channel electrical stimulation treatment device includes two electrical stimulation driving units and two electrical stimulation high-voltage power supplies; the electrical stimulation high-voltage power supplies are connected to the electrical stimulation driving units respectively, and the two electrical stimulation driving units and the two electrical stimulation high-voltage power supplies are connected to the main control chip B respectively.

6. The multifunctional electromyographic biofeedback treatment device according to claim 5, characterized in that: The output signal of one electrical stimulation driving unit is respectively connected to D1, D2, D3, and D4 at one end of the TMUX8211 high-voltage analog switch; the output signal of another electrical stimulation driving unit is connected to one end of connector H, and the other end of connector H is connected to the electrical stimulation electrode; the other end S1 and S3 of the TMUX8211 high-voltage analog switch are respectively connected to connector G, and the other end of connector G is connected to another electrical stimulation electrode.

7. The multifunctional electromyographic biofeedback treatment device according to claim 3, characterized in that: The two-channel ultrasonic therapeutic device also includes two ultrasonic driving units and an RS485 interface C, one ultrasonic driving unit is connected to I2 and I3 at one end of connector I, and the other ultrasonic driving unit is connected to J2 and J3 at one end of connector J; one end I1 of connector I is connected to the other end S2 of the TMUX8211 high-voltage analog switch; one end J1 of connector J is connected to the other end S4 of the TMUX8211 high-voltage analog switch; the main control chip C is respectively connected to the two ultrasonic driving units and the RS485 interface C, and the RS485 interface C is connected to the host computer; there are two two-in-one ultrasonic acupoint stimulation electrodes, one of which is connected to connector I, and the other is connected to connector J.

8. The multifunctional electromyographic biofeedback treatment device according to claim 1, characterized in that: The double-sided composite physical factor treatment terminal includes a shell, a vertical local magnetic vibration composite factor treatment device and an electromyographic biofeedback composite factor treatment device. The shell includes a middle shell and a silicone pad. The middle shell is hollow inside and penetrates each other from top to bottom to form upper and lower openings. The silicone pad is sleeved on the upper opening of the middle shell; the vertical local magnetic vibration composite factor treatment device and the electromyographic biofeedback composite factor treatment device are respectively installed inside the middle shell, and the output end of the vertical local magnetic vibration composite factor treatment device is exposed at the upper opening of the middle shell, and the output end of the electromyographic biofeedback composite factor treatment device is exposed at the lower opening of the middle shell; the planned treatment execution drive unit is respectively connected to the vertical local magnetic vibration composite factor treatment device and the electromyographic biofeedback composite factor treatment device.

9. The multifunctional electromyographic biofeedback treatment device according to claim 8, characterized in that: The vertical local magnetic vibration composite factor therapeutic device includes a vertical local magnetic vibration device, a red light / near infrared unit, a negative pressure air circuit unit and at least one ultrasonic transducer unit, the vertical local magnetic vibration device has a massage head, the red light / near infrared unit has a red light / near infrared light source, the negative pressure air circuit unit has a negative pressure suction port, the ultrasonic transducer unit has an ultrasonic metal head, and the massage head, red light / near infrared light source, negative pressure suction port and ultrasonic metal head are all located at the upper end opening of the middle shell.

10. The multifunctional electromyographic biofeedback treatment device according to claim 8, characterized in that: The electromyographic biofeedback composite factor therapeutic device includes a red light / near infrared unit and at least one ultrasonic transducer unit, the red light / near infrared unit includes a red light / near infrared light source, a PCB board and a light-transmitting panel, a third sinking step for supporting the PCB board is arranged on the inner side of the lower end opening of the middle shell body, and the PCB board is installed on the third sinking step; the red light / near infrared light source is electrically installed on the PCB board; a fourth sinking step is arranged on the inner side of the lower end opening of the middle shell body, and the light-transmitting panel is installed on the fourth sinking step and is located above the red light / near infrared light source; the ultrasonic transducer unit includes an ultrasonic metal head and an ultrasonic ceramic sheet, the ultrasonic metal head is installed on the light-transmitting panel, and the ultrasonic ceramic sheet is located inside the ultrasonic metal head.